TrialBMC cancer2023

Perioperative tislelizumab plus chemotherapy for locally advanced resectable thoracic esophageal squamous cell carcinoma trial: a prospective single-arm, phase II study (PILOT trial).

Chengzhi Ding et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.